Sevion Therapeutics Inc. ("Sevion" or the "Company") (OTCQB:SVON), a
biopharmaceutical company which discovers, develops and acquires
next-generation biologics, today announced a collaboration agreement
with CNA Development, LLC, an affiliate of Janssen Pharmaceuticals, Inc.
(Janssen) to discover antibodies using Sevion’s spatially addressed
... read more